Health
Oxford Coronavirus vaccine update: Phase III trials to conclude by November, mass production expected by 2021 – Times of India
Oxford University backed vaccine is currently in its last stage of testing. The news follows after Russia successfully registered the world’s first COVID-19 vaccine, ‘Sputnik V’ after claiming decent results post completion of phase I.
The announcement also comes after SII head, Adar Poonawallah announced the availability of the vaccine for Indian masses by 2020. In an interview with a media agency recently, he spoke at length, saying:
“We are going to start trials in less than two weeks. The trial is in partnership with ICMR. We will start manufacturing vaccines by the end of August.”
According to revised proposals, the vaccine under the offering, which will be sold and marketed as ‘Covishield’ in India, will involve candid…
-
Noosa News21 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
General23 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out
-
General18 hours agoJordan Thompson retires from Wimbledon round-of-16 match with American Taylor Fritz
-
Noosa News11 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland